Shubham Kumar Shaw

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Estrogen and progesterone-mediated differential modulation of CD4+ T-cell pathogenicity in rheumatoid arthritis
  Frontiers in Immunology 2026 DOI: 10.3389/fimmu.2026.1813310
  +Save
• Meta-inflammation in type 2 diabetes mellitus: unveiling the role of aberrant CD4+ T cells and pro-inflammatory cytokine networks.
  Frontiers in immunology 2025 DOI: 10.3389/fimmu.2025.1603484
  +Save
• “CD4+T Cells drive Inflammation in Type 2 Diabetes Mellitus via the TNF-α/STAT-3 Signaling Pathway”
  2024 DOI: 10.1101/2024.11.20.24317638
  +Save
• Perturbations in spike-specific peripheral T follicular helper cells in SARS-CoV2 breakthrough convalescent individuals immunized by BBV152 vaccine.
  Journal of medical virology 2023 DOI: 10.1002/jmv.29053
  +Save
• IL-21/23 axis modulates inflammatory cytokines and RANKL expression in RA CD4+T cells via p-Akt signaling
  2023 DOI: 10.1101/2023.03.29.23287939
  +Save
• IL-21, inflammatory cytokines and hyper polarized CD8+T cells are central players in Lupus immune pathology
  2022 DOI: 10.1101/2022.10.18.22281177
  +Save
• Defective Mitochondrial Quality Control during Dengue Infection Contributes to Disease Pathogenesis.
  Journal of virology 2022 DOI: 10.1128/jvi.00828-22
  +Save
• Immunomodulation in Autoimmune Disorders
  Immunomodulators and Human Health 2022 DOI: 10.1007/978-981-16-6379-6_10
  +Save
• Underlying Co-Morbidity Reveals Unique Immune Signatures in Type II Diabetes Patients Infected With SARS-CoV2
  Frontiers in Immunology 2022 DOI: 10.3389/fimmu.2022.848335
  +Save